Page last updated: 2024-10-28

idebenone and Multiple Sclerosis

idebenone has been researched along with Multiple Sclerosis in 3 studies

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research Excerpts

ExcerptRelevanceReference
"Idebenone was well tolerated but did not inhibit disability progression or CNS tissue destruction."2.94Idebenone does not inhibit disability progression in primary progressive MS. ( Bielekova, B; Komori, M; Kosa, P; Leinonen, M; Masvekar, R; Phillips, J; Sandford, M; Wichman, A; Wu, T, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Kosa, P1
Wu, T1
Phillips, J1
Leinonen, M1
Masvekar, R1
Komori, M1
Wichman, A1
Sandford, M1
Bielekova, B1
Chang, M1
Szewka, AJ1
Toffoli, D1
Newman, NJ1
Biousse, V1

Trials

1 trial available for idebenone and Multiple Sclerosis

ArticleYear
Idebenone does not inhibit disability progression in primary progressive MS.
    Multiple sclerosis and related disorders, 2020, Volume: 45

    Topics: Axons; Biomarkers; Disease Progression; Double-Blind Method; Humans; Multiple Sclerosis; Multiple Sc

2020

Other Studies

2 other studies available for idebenone and Multiple Sclerosis

ArticleYear
Leber's hereditary optic neuropathy misdiagnosed as optic neuritis and Lyme disease in a patient with multiple sclerosis.
    BMJ case reports, 2018, Dec-07, Volume: 11, Issue:1

    Topics: Adult; Antioxidants; Diagnosis, Differential; Diagnostic Errors; Humans; Lyme Disease; Magnetic Reso

2018
Updates in neuro-ophthalmology. Highlights from the 37th annual meeting of the North American Neuro-Ophthalmology Society,February 5-10, 2011, Vancouver, Canada.
    Reviews in neurological diseases, 2011, Volume: 8, Issue:1-2

    Topics: Burkholderia; Canada; Giant Cell Arteritis; Humans; Multiple Sclerosis; Neurology; Ophthalmology; Op

2011